Avalo Therapeutics, Inc. (AVTX)
14.41
-1.51
(-9.48%)
USD |
NASDAQ |
Apr 08, 16:00
14.41
0.00 (0.00%)
After-Hours: 07:07
Avalo Therapeutics Total Liabilities (Quarterly) : 34.65M for Dec. 31, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| AbbVie, Inc. | 137.19B |
| Corcept Therapeutics, Inc. | 190.22M |
| Catalyst Pharmaceuticals, Inc. | 152.54M |
| Relmada Therapeutics, Inc. | 7.492M |
| Theravance Biopharma, Inc. | 188.85M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 117.70M |
| Shareholders Equity (Quarterly) | 83.05M |
| Debt to Equity Ratio | 0.0292 |
| Current Ratio | 8.136 |
| Net Debt Paydown Yield | -0.05% |